If you need more lookups,
subscriptions start at $34 USD/month.
Jeff Vernimb Location
Jensen Beach, FL, US
Jeff Vernimb Work
Board Member @ Innovation Hold Co I NV (April 2021 - Present)
Acting President @ Oystershell Consumer Health (July 2020 - March 2021)
Senior Vice-President Global Consumer Health and North American General Manager @ Moberg Pharma (January 2018 - April 2019)
General Manager @ Moberg Pharma (December 2014 - January 2018)
Vice President of U.S. Sales and Canada Marketing and Sales @ Insight Pharmaceuticals (May 2011 - December 2014)
Vice-President of Marketing and Sales @ Dynova Laboratories (March 2008 - May 2011)
Vice-President Global Marketing @ (August 2005 - August 2007)
Vice President Marketing @ (November 2001 - January 2005)
Sr. Director Customer Marketing @ (October 1990 - October 2001)
Director Customer Marketing @ (January 1997 - January 1998)
Jeff Vernimb Education
Rider University
BS (Marketing)
1981-1985
Jeff Vernimb Skills
Cross-functional Team Leadership
Start-ups
Marketing
FMCG
Advertising
B2B
Strategic Planning
Entrepreneurship
Sales
Retail
Trade Marketing
Budgets
Pharmaceutical Industry
Business Intelligence
Global Marketing
Coaching
Project Planning
Categorization
Procurement
Consumer Products
Sales Operations
Strategy
Competitive Analysis
Marketing Strategy
P&L Management
Integrated Marketing
Business Development
Product Launch
Brand Management
Sales Management
Customer Insight
Start Ups
Cross Functional Team Leadership
Jeff Vernimb Summary
Jeff Vernimb, based in Jensen Beach, FL, US, is currently a Board Member at Innovation Hold Co I NV. Jeff Vernimb brings experience from previous roles at Oystershell Consumer Health, Moberg Pharma and Insight Pharmaceuticals. Jeff Vernimb holds a 1981 - 1985 BS in Marketing @ Rider University. With a robust skill set that includes Cross-functional Team Leadership, Start-ups, Marketing, FMCG, Advertising and more. Jeff Vernimb has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Jeff Vernimb?
Find contact details for 700 million professionals.